about
Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in SpainKnowledge and understanding of urinary incontinence: survey of family practitioners in northern Alberta.Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence.Knowledge of the Disease, Perceived Social Support, and Cognitive Appraisals in Women with Urinary IncontinenceThe medical treatment of overactive bladder, including current and future treatments.Overactive bladder symptoms and voiding dysfunction in neurologically normal women.Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder.Impact of Loss of Work Productivity in Patients with Overactive Bladder Treated with Antimuscarinics in Spain: Study in Routine Clinical Practice Conditions.Adherence to professional guidelines for patients with urinary incontinence by general practitioners: a cross-sectional study.Effectiveness of involving a nurse specialist for patients with urinary incontinence in primary care: results of a pragmatic multicentre randomised controlled trial.Evidence-based healthcare, clinical knowledge and the rise of personalised medicine.
P2860
Q33588346-1211EAFC-E13A-4D15-858C-3B277D866FC6Q37008174-3F1B8B0B-B45D-4144-B785-8E033C4484DBQ37325841-6855D251-688F-4E36-9CCF-2EC13B763066Q37554053-AC87814C-A550-4A15-9F0E-7E25E17F7D01Q37836943-01E9087F-7B8D-4A49-9387-E78DF1ACD0C5Q37993791-1981D53D-031A-43D2-BF63-A69D73D42420Q38231743-7EFF58E9-51DB-45CC-8E72-994387B12A6EQ40321896-F3002D87-D983-49E6-9D35-9FD14EA194A8Q48344931-17C1072F-C889-4A33-A407-A338AB89D24AQ48671203-45FC45A7-F81D-416F-8861-97A74AFB5530Q53124097-8C508374-8168-4DB0-B331-42AD01F5C110
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Overactive bladder: The importance of new guidance.
@ast
Overactive bladder: The importance of new guidance.
@en
type
label
Overactive bladder: The importance of new guidance.
@ast
Overactive bladder: The importance of new guidance.
@en
prefLabel
Overactive bladder: The importance of new guidance.
@ast
Overactive bladder: The importance of new guidance.
@en
P2093
P2860
P1476
Overactive bladder: The importance of new guidance
@en
P2093
Artibani W
De Ridder D
Espuna-Pons M
Kelleher C
Van Kerrebroeck P
P2860
P304
P356
10.1111/J.1742-1241.2006.01127.X
P577
2006-10-01T00:00:00Z